About: Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Drug Manufacturers - General
Latest price: $2.90 (+1.05%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
NSRX NYSE Nasus Pharma Ltd.
Nasus Pharma Ltd. share price
NSRX price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
NSRX price performance
NSRX Market Signals